Sagiment Biosciences Stock Quote SGMT - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

4.32

Bid

4.33

Ask

6.50

Volume

770,647

4.25 Day's Range 4.76

2.13 52 Week Range 20.71

Market Cap

92.342M

Previous Close

4.45

Open

4.62

Last Trade

4.62

Last Trade Time

Financial Volume

$ 3,439,040

VWAP

4.4625

Average Volume (3m)

860,880

Shares Outstanding

21,375,402

Dividend Yield

PE Ratio

-3.31

Earnings Per Share (EPS)

-1.3

Revenue

Net Profit

-27.88M

Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. Its lead drug candidate is Denifanstat, a FASN inhibitor for the treatment ... Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. Its lead drug candidate is Denifanstat, a FASN inhibitor for the treatment of nonalcoholic steatohepatitis and acne. The company is also developing TVB-3567, a FASN inhibitor for the treatment of various types of cancers. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Headquarters

Camden, Delaware, USA

Founded

1970

Sagiment Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SGMT. The last closing price for Sagiment Biosciences was $4.45. Over the last year, Sagiment Biosciences shares have traded in a share price range of $ 2.13 to $ 20.71.

Sagiment Biosciences currently has 21,375,402 shares outstanding. The market capitalization of Sagiment Biosciences is $92.34 million. Sagiment Biosciences has a price to earnings ratio (PE ratio) of -3.31.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.32	8	4	4.95	3.88	567162	4.21504847	CS
4	-1.07	-19.8515769944	5.39	5.56	3.83	418455	4.47940225	CS
12	-1.73	-28.5950413223	6.05	8.75	3.83	860880	5.64865406	CS
26	0.48	12.5	3.84	20.71	2.13	998197	10.31957329	CS
52	-11.18	-72.1290322581	15.5	20.71	2.13	663889	10.41185826	CS
156	-11.18	-72.1290322581	15.5	20.71	2.13	663889	10.41185826	CS
260	-11.18	-72.1290322581	15.5	20.71	2.13	663889	10.41185826	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BENFBeneficient	$ 6.8001 (254.17%)	31.01M
SGBXSafe and Green Holdings Corporation	$ 5.49 (87.37%)	92.18M
SHOTWSafety Shot Inc	$ 0.45 (45.16%)	644
AIPArteris Inc	$ 8.185 (38.03%)	1.11M
RGFReal Good Food Company Inc	$ 0.85 (37.32%)	4.26M
MNDRMobile health Network Solutions	$ 3.33 (-84.91%)	18.76M
NUVOHoldco Nuvo Group DG Ltd	$ 2.00 (-57.54%)	1.04M
SPTSprout Social Inc	$ 28.82 (-40.15%)	13.47M
UNITUniti Group Inc	$ 4.441 (-26.35%)	21.07M
IPDNProfessional Diversity Network Inc	$ 1.29 (-24.12%)	662.59k
AAPLApple Inc	$ 183.38 (5.98%)	163.22M
SQQQProShares UltraPro Short QQQ	$ 11.08 (-5.94%)	154.59M
JAGXJaguar Health Inc	$ 0.3164 (7.91%)	142.47M
NKLANikola Corporation	$ 0.6526 (6.55%)	106.88M
SGBXSafe and Green Holdings Corporation	$ 5.49 (87.37%)	92.18M